A phase II clinical trial of celecoxib combined with platinum-based regimen as first-line chemotherapy for advanced non-small cell lung cancer patients with cyclooxygenase-2 positive expression

2009 ◽  
Vol 21 (1) ◽  
pp. 1-12 ◽  
Author(s):  
Jun Zhao ◽  
Zhi-jie Wang ◽  
Jian-chun Duan ◽  
Qing-zhi Guo ◽  
Hua Bai ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
Positive Expression ◽  
Line Chemotherapy

NON-SMALL-CELL LUNG CANCER PATIENTS UNSUITABLE FOR FIRST-LINE CHEMOTHERAPY: A NEW CATEGORY OF PATIENTS FOR CLINICAL STUDIES?

2005 ◽  
Vol 53 (6) ◽  
pp. 1078-1079
Author(s):  
Héctor J. Soto Parra ◽  
Fiorenza Latteri ◽  
Raffaele Cavina ◽  
Fabio De Vincenzo ◽  
Paolo A. Zucali ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Clinical Studies ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document